SCHEMBL30015334

SCHEMBL30015334

CC(C)(C)OC(=O)N1CC(N2CCc3cc(Br)ccc3C2)C1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 1/20 0.54
ABHD6 Q9BV23 3/20 0.47
NR1H2 P55055 1/20 0.47
USP30 Q70CQ3 2/20 0.44
NAMPT P43490 1/20 0.44
FPR2 P25090 2/20 0.44
PRMT5 O14744 2/20 0.42
WDR77 Q9BQA1 2/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
RORC P51449 2/20 0.41
HDAC1 Q13547 1/20 0.41
DDB1 Q16531 1/20 0.41
CRBN Q96SW2 1/20 0.41
HSD17B3 P37058 1/20 0.39
FAAH O00519 1/20 0.39
KRAS P01116 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25882590 1.00 ESR2 (0.54) ESR2ABHD6NR1H2USP30NAMPT
SCHEMBL30612405 0.92 ESR2 (0.51) ESR2ABHD6NR1H2USP30NAMPT
SCHEMBL20045530 0.91 USP30 (0.47) ESR2ABHD6NR1H2USP30NAMPT
SCHEMBL27227646 0.90 ESR2 (0.53) ESR2ABHD6NR1H2USP30NAMPT
SCHEMBL30658387 0.90 ESR2 (0.53) ESR2ABHD6NR1H2USP30NAMPT
SCHEMBL21467241 0.88 NR1H2 (0.50) ESR2ABHD6NR1H2USP30FPR2
SCHEMBL587847 0.84 ESR2 (0.74) ESR2ABHD6NR1H2NAMPTNPC1
SCHEMBL29528794 0.84 ESR2 (0.74) ESR2ABHD6NR1H2NAMPTNPC1
SCHEMBL29113466 0.83 ESR2 (0.53) ESR2NR1H2NAMPTPRMT5WDR77
SCHEMBL26962979 0.82 ABHD6 (0.45) ABHD6PRMT5NPC1RAB9AHSD17B3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4291177-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING FGF ACTIVITY Recovery Therapeutics, Inc. (US) 2023-12-20 EP disclosed
WO-2022174083-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING FGF ACTIVITY RECOVERY THERAPEUTICS, INC. (US) 2022-08-18 WO disclosed